147 related articles for article (PubMed ID: 1373678)
1. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
[TBL] [Abstract][Full Text] [Related]
2. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
Kunimi K; Uchibayashi T; Hisazumi H
Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
Xue H; Situ ZQ; Wang CJ; Wu JZ
Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
[TBL] [Abstract][Full Text] [Related]
6. Association of activated proto-oncogenes ras and myc in colorectal carcinomas.
Smith DR; Elnatan J; Myint T; Goh HS
Ann Acad Med Singap; 1995 May; 24(3):393-8. PubMed ID: 7574421
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-myc and c-fos mRNA in colorectal carcinoma in man.
Klimpfinger M; Zisser G; Ruhri C; Pütz B; Steindorfer P; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):165-71. PubMed ID: 1980763
[TBL] [Abstract][Full Text] [Related]
8. [The expression of oncogenes in the development of human brain].
Sun N; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):9-12. PubMed ID: 1398634
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
10. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
[TBL] [Abstract][Full Text] [Related]
11. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice.
Butterworth BE; Sprankle CS; Goldsworthy SM; Wilson DM; Goldsworthy TL
Mol Carcinog; 1994 Jan; 9(1):24-32. PubMed ID: 8297482
[TBL] [Abstract][Full Text] [Related]
12. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in skin tumors induced in hairless mice by chronic exposure to ultraviolet B irradiation.
Sato H; Suzuki JS; Tanaka M; Ogiso M; Tohyama C; Kobayashi S
Photochem Photobiol; 1997 May; 65(5):908-14. PubMed ID: 9155265
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
Orian JM; Vasilopoulos K; Yoshida S; Kaye AH; Chow CW; Gonzales MF
Br J Cancer; 1992 Jul; 66(1):106-12. PubMed ID: 1322154
[TBL] [Abstract][Full Text] [Related]
16. Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erb B2, and c-Ha-ras.
Kim YJ; Ghu HD; Kim DY; Kim HJ; Kim SK; Park CS
J Surg Oncol; 1993 Nov; 54(3):167-70. PubMed ID: 8412172
[TBL] [Abstract][Full Text] [Related]
17. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene expression in dermal naevi and melanomas.
Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
Arch Dermatol Res; 1991; 283(8):500-5. PubMed ID: 1686168
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cellular oncogenes during rat liver development.
Zhang XK; Wang Z; Lee A; Huang DP; Chiu JF
Cancer Lett; 1988 Aug; 41(2):147-55. PubMed ID: 2456853
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
